RA-SURE - art photonics

Latest News

22 April 2024

Viacheslav Artyushenko Honored with EPIC Lifetime Achievement Award

By Stanislav Perevoschikov

We’re excited to share some fantastic news! Viacheslav Artyushenko, our CEO & Founder, has been honored with the EPIC Lifetime Achievement Award by the European Photonics Industry Consortium (EPIC). This award celebrates his significant contributions to the optical fiber industry and his exceptional leadership. Viacheslav has led art photonics GmbH to become a key player […]

22 April 2024

New Collaboration: NLIR Spectrometers with Our Fiber Optic Probes!

By Stanislav Perevoschikov

art photonics is proud to announce a transformative collaboration with NLIR, a fellow subsidiary of Nynomic AG. This partnership is set to redefine standards in remote process-control and in-line monitoring through the integration of state-of-the-art Fiber Coupled NLIR Spectrometers with art photonics’ fiber optic probes. Integrated Solutions for Enhanced Precision Our combined technologies leverage the […]

Latest Events

14 March 2024

APACT 2024 | 23-25 April 2024, New Brunswick, NJ, USA

By Stanislav Perevoschikov

We are excited to share that our CEO, Viacheslav Artyushenko, will be attending and presenting at APACT 2024, a key event for leaders in process monitoring, data analysis, process modeling, and control. As proud sponsors of this conference, art photonics is at the forefront of advancing Process Analytical Technology (PAT) and fostering significant progress across […]

13 March 2024

Analytica 2024 | 09–12 April, 2024, Munich, Germany

By Stanislav Perevoschikov

Join art photonics at Analytica 2024! We are happy to announce our participation in Analytica 2024, taking place from April 09 to 12, 2024, in Munich, Germany! We are more than eager to present our pioneering fiber optic solutions that define precision in remote spectroscopic measurements and are at the forefront of combining analytical methods, […]

Ra-Sure: Raman spectroscopy guided tumour surgery

Oral cavity cancer is a major public health issue, with annually 300.000 new cases and a 50% 5-year survival. Surgery is the mainstay of treatment, but adequate tumour removal is not achieved in 85% of the cases. This affects survival and leads to additional treatment of patients by radiotherapy or chemotherapy. The hands and eyes of the surgeon are insufficient for tumour delineation in the oral cavity. Significant improvement is needed to improve the surgical success rate.

In frames of Ra-Sure, a fully automated Raman spectroscopic device is under development to achieve complete tumour removal in oral cancer surgeries. The product will consist of a dedicated Raman-based tissue inspection device, the operational system and disposable fibre-optic needle probes

A fully automatic inspection device (Ra-Sure) that can perform differentiation between cancer and healthy oral tissues will be developed to the point where it can enter clinical trials. At the end of the project the device will enable rapid (within 15 minutes) inspection of surgically removed tissue in the operating room. As such, surgical removal will be effective in 50% instead of current 15% of the cases. The direct customers of the product will be surgeons and pathologists. As part of the go-to-market strategy, key opinion leaders in oral cancer will be addressed first.

The role of art photonics is the development of the unique Raman fibre-optic needle that can be inserted into the tissue multiple times and measure without loss of quality of the results.

Project Partners

Project Funders